試す - 無料

“The biggest challenge that India is facing now is the skewed ratio between population & limited resources”

BioSpectrum Asia

|

May 2020

BIOSPECTRUM WEBINAR ON “EXPLORING VARIOUS ASPECTS OF COVID-19”

- Kalyani Sharma

“The biggest challenge that India is facing now is the skewed ratio between population & limited resources”

As the number of COVID-19 cases continue to rise all across the globe, healthcare authorities and experts are coming together to identify gaps and work together to accelerate and fund priority research needed to help stop this outbreak and prepare for any future outbreaks. With an aim of exploring the various aspects associated with the COVID-19 pandemic, BioSpectrum India conducted a webinar on April 16, which saw participation of industry experts sharing their views on how can India tackle this outbreak.

Hailing the government’s efforts and initiatives in controlling the spread of pandemic COVID-19 in India industry experts suggest few measures to move to normal daily life and bring cheer among the daily wagers who have been the most affected. The suggestions include Fast-Track Approval of Innovations; Scaling-up the number of testing labs and Manufacturing set-ups; More Public-Private Partnerships; Developing Rapid-Tests and Proper Functioning of Logistics and Transportation.

The above suggestions were made during a webinar organised by BioSpectrum India on “Exploring Various Aspects of COVID-19” on April 16. Participating in the webinar Dr Rajeev M. Dhere, Executive Director & Dr Suresh Jadhav, Executive Director, Serum Institute of India Pvt Ltd, Pune; Dr Taslimarif Saiyed, CEO & Director, Centre for Cellular and Molecular Platforms (C-CAMP), Bengaluru; Dr Priti V. Warke, Director- Cell Culture, Head- Regulatory Affairs, HiMedia Laboratories, Mumbai and Satyaki Banarjee, CEO- Medical Imaging, Trivitron Healthcare, Mumbai shared their views on various crucial aspects of this pandemic such as What are the current challenges facing India in countering this fight?What are the resources available and what more is required?What needs to be done so that India is more prepared for a future pandemic situation? And what is the impact on the Indian economy?

Challenges

BioSpectrum Asia からのその他のストーリー

BioSpectrum Asia

BioSpectrum Asia

Collaborative R&D: Partnerships shaping the future of biopharma

Biotechs and pharma companies face rising costs of drug development, depleting R&D pipelines and diminishing returns on investment. By joining forces and exploring collaborative R&D partnerships it is possible to overcome these challenges. In addition to sharing risks, they share the potential rewards when their assets move further into clinical development or come to the market.

time to read

2 mins

BioSpectrum Asia Sep 2025

BioSpectrum Asia

BioSpectrum Asia

Quantum Computing: Future of diagnostics is being coded today

A silent revolution is being built at the intersection of biology and quantum physics. After decades of pushing the boundaries of diagnostics with advanced imaging and AI, we are now approaching a hard computational wall. For complex conditions like Alzheimer's, Parkinson's, and many cancers, the interacting variables of genomics, proteomics, and real-world patient data are simply too vast for classical computers to master. This limitation caps the ability to move from merely spotting correlations to uncovering true causation. Unlike traditional AI, quantum computing can simulate underlying physical systems to derive precise solutions. The transition from correlational analysis to causal simulation will enable a more valuable and advanced frontier in diagnostics.

time to read

4 mins

BioSpectrum Asia Sep 2025

BioSpectrum Asia

First Pacific woman to serve as public health director in NZ

The Ministry of Health in New Zealand (NZ) has appointed Dr Corina Grey as the new Director of Public Health this year, a landmark appointment for Pacific leadership.

time to read

1 min

BioSpectrum Asia Sep 2025

BioSpectrum Asia

Bio-Rad appoints Rajat Mehta as Executive Vice President of Global Commercial Operations

Bio-Rad Laboratories, Inc., a global leader in life science research and clinical diagnostics products, has announced the appointment of Rajat Mehta as its new Executive Vice President, Global Commercial Operations, effective August 4, 2025.

time to read

1 min

BioSpectrum Asia Sep 2025

BioSpectrum Asia

BioSpectrum Asia

Hugel launches botulinum toxin Letybo in Malaysia

South Korea-based Hugel Inc., a leading global medical aesthetics company, has officially launched its botulinum toxin product Letybo in Malaysia - an emerging market for medical aesthetics in Southeast Asia.

time to read

1 min

BioSpectrum Asia Sep 2025

BioSpectrum Asia

BioSpectrum Asia

Australia designs smart wound monitor to improve chronic infection care

Researchers from Australia's RMIT University have developed a wearable wound monitoring device with integrated sensors that could reduce infection risks by minimising the need for frequent physical contact.

time to read

1 min

BioSpectrum Asia Sep 2025

BioSpectrum Asia

Revvity unveils innovative reagent technology to accelerate therapeutics development

US-based Revvity, Inc. has announced the launch of pHSense reagents, a powerful technology designed to advance internalisation studies in drug discovery.

time to read

1 min

BioSpectrum Asia Sep 2025

BioSpectrum Asia

BioSpectrum Asia

Sanofi acquires next-gen vaccine biotech Vicebio for $1.6 B

Vicebio, a biopharmaceutical company with operations in Australia, UK and Belgium, has entered an exclusive, definitive agreement to be acquired by Sanofi.

time to read

1 min

BioSpectrum Asia Sep 2025

BioSpectrum Asia

HOSMAC signs MoU with Gulf Medical University to strengthen healthcare education

HOSMAC, Asia's leading hospital planning, design, and management consultancy, has signed a Memorandum of Understanding (MoU) with Gulf Medical University (GMU), Ajman, UAE, to serve as an industry partner.

time to read

1 min

BioSpectrum Asia Sep 2025

BioSpectrum Asia

Jessica Cowden takes charge as Deputy Director General of CARE unit at IVI

Dr Jessica Cowden has been appointed Deputy Director General of the Clinical, Assessment, Regulatory, Evaluation (CARE) unit at South Korea-headquartered International Vaccine Institute (IVI). She will continue to be based at IVI's Europe Regional Office in Stockholm, Sweden.

time to read

1 min

BioSpectrum Asia Sep 2025

Translate

Share

-
+

Change font size